Drug Trial Radar · NCT07170150
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,060
Actual
Start
Nov 12, 2025
Primary completion
Feb 16, 2028
Study completion Feb 16, 2028
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).
Conditions
- Alzheimers Disease
Interventions
TrontinemabDrug
Participants will receive IV trontinemab
PlaceboOther
Participants will receive IV placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 72 in Clinical Dementia Rating, Sum of Boxes (CDR-SB)Time frame: Baseline - Week 72
Locations
147 sites in 16 countries. Site status is shown where the registry gives one.
Banner Alzheimer?s Institute
Phoenix, Arizona
Sun Valley Research Center, Inc.
Imperial, California
Healthy Brain Clinic
Long Beach, California
Oakland Clinical
Oakland, California
Riverside Clinical
Riverside, California
Cenexel California Neuroscience Research, LLC
Sherman Oaks, California
Yale University
New Haven, Connecticut
JEM Research LLC
Atlantis, Florida
K2 Medical Research-Winter Garden
Clermont, Florida
Visionary Investigators Network- Neurology Aventura
Miami, Florida
Charter Research - Winter Park/Orlando
Orlando, Florida
Conquest Research - Lake Nona
Orlando, Florida
Alzheimer's Research and Treatment Center
Stuart, Florida
CenExel iResearch, LLC
Decatur, Georgia
Center for Advanced Research & Education
Gainesville, Georgia
Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville
Chicago, Illinois
Adams Clinical Boston
Boston, Massachusetts
Adams Clinical Watertown
Watertown, Massachusetts
Quest Research Institute
Farmington Hills, Michigan
University of Nebraska Medical Center
Omaha, Nebraska
The Cognitive and Research Center of New Jersey
Springfield, New Jersey
IMA Clinical Research - Albuquerque
Albuquerque, New Mexico
AD-CARE, University of Rochester Medical Center
Rochester, New York
Summit Research Network Inc.
Portland, Oregon
Flourish Research ? Philadelphia
Plymouth Meeting, Pennsylvania
Palmetto Clinical Trials
Summerville, South Carolina
Gadolin Research, LLC
Beaumont, Texas
Kerwin Medical Center
Dallas, Texas
Re:Cognition Health - Fort Worth
Fort Worth, Texas
Mt.Olympus Medical Research
Katy, Texas
El Faro Health and Therapeutics
Rio Grande City, Texas
Sana Research, LLC
Arlington, Virginia
Re:Cognition Health
Fairfax, Virginia
CIER
C. A. B. A., Argentina
Fundacion Scherbovsky
Mendoza, Argentina
INECO Neurociencias Orono
Rosario, Santa Fe Province, Argentina
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Southern Neurology
Kogarah, New South Wales, Australia
KaRa Institute of Neurological Diseases
Macquarie Park, New South Wales, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
Showing 40 of 147 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.